Literature DB >> 1347421

A new TaqI polymorphism in the p53 gene.

A Serra1, G L Gaidano, D Revello, A Guerrasio, P Ballerini, R Dalla Favera, G Saglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1347421      PMCID： PMC312060          DOI： 10.1093/nar/20.4.928

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  1 in total

1.  A variation in the structure of the protein-coding region of the human p53 gene.

Authors:  V L Buchman; P M Chumakov; N N Ninkina; O P Samarina; G P Georgiev
Journal:  Gene       Date:  1988-10-30       Impact factor: 3.688
  1 in total
  5 in total

1.  Novel cell lines established from pediatric brain tumors.

Authors:  Jingying Xu; Anat Erdreich-Epstein; Ignacio Gonzalez-Gomez; Elizabeth Y Melendez; Goar Smbatyan; Rex A Moats; Michael Rosol; Jaclyn A Biegel; C Patrick Reynolds
Journal:  J Neurooncol       Date:  2011-11-27       Impact factor: 4.130

2.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

3.  Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.

Authors:  E Ricevuto; C Ficorella; C Fusco; K Cannita; A Tessitore; E Toniato; A Gabriele; L Frati; P Marchetti; A Gulino; S Martinotti
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

4.  p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.

Authors:  K Honda; E Sbisà; A Tullo; P A Papeo; C Saccone; S Poole; M Pignatelli; R R Mitry; S Ding; A Isla; A Davies; N A Habib
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Prognostic significance of TP53 alterations in breast carcinoma.

Authors:  T I Andersen; R Holm; J M Nesland; K R Heimdal; L Ottestad; A L Børresen
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.